title: Sclerotherapy for hydroceles.
abstract: Sclerotherapy with 3% sodium tetradecyl sulfate and 3.5% rolitetracycline on an outpatient basis was applied to 55 hydroceles. The over-all cure rate was 96% with an average followup of 13 months. Of the patients 64% were cured after only 1 sclerosant instillation. A post-sclerotherapy operation was necessary in 4% of the patients. Pain of a significant degree occurred after sclerotherapy in only 29% of the patients. Sclerotherapy appears to be an effective, economical and safe form of outpatient therapy for hydroceles.
authors.affiliation: Department of Urology, Medical University of Southern Africa, Pretoria.
authors.forename: R K
authors.initials: RK
authors.lastname: Rencken
authors.forename: M S
authors.initials: MS
authors.lastname: Bornman
authors.forename: S
authors.initials: S
authors.lastname: Reif
authors.forename: I
authors.initials: I
authors.lastname: Olivier
mesh_terms: D000553:Ambulatory Care; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D012008:Recurrence; D012382:Rolitetracycline / Q000008:administration & dosage; D015911:Sclerotherapy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D012981:Sodium Tetradecyl Sulfate / Q000008:administration & dosage; D006848:Testicular Hydrocele / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*
chemical_list: D012382:Rolitetracycline; D012981:Sodium Tetradecyl Sulfate